Manufactures and markets cosmetic ingredients for various applications. Produces medical lubricants for use in medical procedures and devices. Now — the numbers.
Revenue is spread across several lines; no single product carries the company.
This is an established company with proven profits.
If every debt were paid off today, $8.6M would still be left in the vault — a solid cushion for hard times.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
Debt is low and cash is strong; the finances stand solid.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Growth: Sales growth trails the sector average.
An investor who bought at the very peak is down 72% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The net profit margin is 20% — still a thick cushion, though costs have been eating into it lately.
There is $8.6M in the vault; even if every debt were paid off, $8.6M would remain.
It pays out $0.30 per share each year — regular cash for whoever holds the stock.
Over the last 4 years, sales fell about 7% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
The growth engine is running at low revs right now. Report-card grade: 17/100.
On our five-subject report card, UG sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: UG is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Not covered, because the filings we hold do not carry it: earnings execution.